Summary of Drugs and Manners of Administration Subject to Price Disclosure
pre-1 December 2010

Please note: The information on this page is no longer current and is only included here for historical reference. Up to date information can be found on the Price Disclosure (EAPD) page.

 

First Round of PBS Price Disclosure – Assessed for potential reduction on 1 December 2009
First Round of PBS Price Disclosure - December 2009

Drug

MOA

amisulpride

oral

doxorubicin

injection/intravesical

fosinopril with hydrochlorothiazide

oral

meloxicam

oral

mitozantrone

injection

ondansetron

injection

oxybutynin

oral

perindopril with indapamide

oral

valproic acid

oral

 

Second Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Second Round of PBS Price Disclosure – April 2010

Drug

MOA

alendronic acid

oral

ceftriaxone

injection

fluconazole

injection

fluconazole

oral

naltrexone

oral

vancomycin

injection

 

Third Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Third Round of PBS Price Disclosure – April 2010

Drug

MOA

carvedilol

oral

enalapril with hydrochlorothiazide

oral

irinotecan

injection

sumatriptan

oral

 

Fourth Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2010
Fourth Round of PBS Price Disclosure – August 2010

Drug

MOA

amisulpride

oral

bicalutamide

oral

cefalotin

injection

doxorubicin

injection/intravesical

fosinopril with hydrochlorothiazide

oral

meloxicam

oral

mitozantrone

injection

ondansetron

injection

oxybutynin

oral

perindopril with indapamide

oral

valproic acid

oral

 

Fifth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Fifth Round of PBS Price Disclosure – April 2011

Drug

MOA

alendronic acid

oral

ceftriaxone

injection

cisplatin

injection

fluconazole

injection

fluconazole

oral

fludarabine

injection

naltrexone

oral

risperidone

oral

vancomycin

injection

 

Sixth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Sixth Round of PBS Price Disclosure – April 2011

Drug

MOA

carvedilol

oral

enalapril with hydrochlorothiazide

oral

gemcitabine

injection

irinotecan

injection

paclitaxel

injection

sumatriptan

oral

vinorelbine

injection

 

Seventh Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2011
Seventh Round of PBS Price Disclosure – August 2011

Drug

MOA

alendronic acid with colecalciferol

oral

amisulpride

oral

azithromycin

oral

bicalutamide

oral

bisoprolol

oral

cabergoline

oral

cefalotin

injection

doxorubicin

injection/intravesical

escitalopram

oral

fosinopril with hydrochlorothiazide

oral

glucose

injection

meloxicam

oral

mitozantrone

injection

morphine

oral

ondansetron

injection

ondansetron

oral

oxaliplatin

injection

oxybutynin

oral

perindopril with indapamide

oral

sodium chloride

injection

sodium lactate compound

injection

valproic acid

oral

 

This list includes all drugs and manners of administration subject to price disclosure arrangements in each cycle pre-1 December 2010 (i.e. prior to arrangements becoming expanded and accelerated).